BRAIN Biotech 

€1.52
6
-€0.07-4.4% Friday 15:30

Statistiques

Jour Haut
-
Journée basse
-
52W Haut
-
52W Bas
-
Volume
-
Volume moyen
-
Cap boursière
37.03M
Ratio C/B
-
Rendement de dividendes
-
Dividende
-

À venir

Bénéfices

28MayPrévu
Q1 2022
Q2 2022
Q4 2022
Q1 2023
Q2 2023
Q4 2023
Q1 2024
999
333
-333
-999
BPA prévu
S. O.
BPA réel
S. O.

Sont également suivis

Cette liste est basée sur les listes de surveillance des personnes sur Stock Events qui suivent BNN.XETRA. Il ne s'agit pas d'une recommandation d'investissement.

Concurrents

Cette liste est une analyse basée sur les événements récents du marché. Ce n'est pas une recommandation d'investissement.

À propos de nous

BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. It also provides biocatalysts and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
Show more...
PDG
Mr. Adriaan Moelker
Employés
322
Pays
DE
ISIN
DE0005203947
WKN
000520394

Cotation